M.J. Alcaraz

INCLIVA Health Research Institute

Papers

1

Total Citations

11

H-Index

1

About

Dr. M.J. Alcaraz is a leading figure in molecular diagnostics and infectious disease research, with a particular focus on enhancing the accuracy of SARS-CoV-2 detection. Their most-cited work, “Amplification of human β‐glucuronidase gene for appraising the accuracy of negative SARS‐CoV‐2 RT‐PCR results in upper respiratory tract specimens” (2020, 11 citations), addresses a critical challenge in COVID-19 testing: the high rate of false-negative RT-PCR results. By introducing a novel internal control strategy using the human β-glucuronidase gene, Alcaraz provided a method to verify sample quality and reduce diagnostic errors, directly improving clinical decision-making during the pandemic. This contribution underscores their expertise in assay optimization and quality assurance in virology. Alcaraz’s research has been instrumental in refining laboratory protocols, offering a practical solution to a pressing global health issue. Their work continues to influence diagnostic standards, demonstrating a commitment to precision and reliability in molecular testing.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Amplification of human β‐glucuronidase gene for appraising the accuracy of negative SARS‐CoV‐2 RT‐PCR results in upper respiratory tract specimens
11 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: INCLIVA Health Research Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago